baber/WOPTO huggingface dataset:
Patent NZ-247553-A (NZ)
Title: Consensed tri- or tetra-cyclic hetero macrolide derivatives and pharmaceutical compositions
Inventor: BAUMANN KARL
IPC: C07D/
Filed: 1993-05-05
Abstract: The invention concerns the compounds of formulae <CHEM> wherein the substituents have various significances. They can be prepared by various methods, e.g. acylation, reduction, alkylation, etc. They are indicated for use as pharmaceuticals, in particular as immunosuppressant, antiproliferative and antiinflammatory agents.
Patent NZ-270020-A (NZ)
Title: Various (phenoxy)acetic acid derivatives, the acid moiety having amino(methylimino) and/or azaheterocyclic and/or carbamoyl containing substituents among others
Inventor: ALIG LEO
IPC: C07C259/18
Filed: 1994-11-29
Abstract: Acetic acid derivatives of the formula <IMAGE> in which L, M, Q and T have the meaning stated in the description, can be used for the treatment or prophylaxis of diseases caused by the binding of adhesive proteins to blood platelets, and by aggregation of blood platelets and cell-cell adhesion. They are prepared by eliminating protective groups in corresponding protected compounds or by converting the cyano group into the amidino group in corresponding nitriles.
Patent NZ-271878-A (NZ)
Title: Cytokines; hek ligand (hek-l) polypeptides, dna sequences, vectors and transformed host cells
Inventor: BECKMANN MARY PATRICIA
IPC: A61K38/00
Filed: 1994-08-17
Abstract: Hek ligand (hek-L) polypeptides as well as DNA sequences, vectors and transformed host cells useful in providing hek-L polypeptides. The hek-L polypeptides bind to a cell surface receptor (hek) that is a member of the receptor tyrosine kinase family. Hek is expressed on cells that include certain tumor cell lines. The hek-L polypeptides also bind a distinct receptor tyrosine kinase known elk.
Patent NZ-309777-A (NZ)
Title: Method for the detection of compounds that modulate the effects of the obese protein
Inventor: BEELEY LEE JAMES
IPC: C12Q1/68
Filed: 1996-05-28
Abstract: escribed is a method for the detection of a compound that mimics, potentiates or inhibits the physiological effect of the ob-protein.  The method comprises: (a)	for a compound which mimics the physiological effect of the ob-protein, assessing for the effect of the compound upon an ob-protein activated signal transducer and activator of transcription (STAT) DNA response element coupled to a reporter gene; or (b)	for a compound which potentiates or inhibits the physiological effect of the ob-protein assessing the effect of the compound upon the response provided by ob-protein upon an ob-protein activated STAT DNA response element coupled to a reporter gene; the response element and the reporter being expressed in an ob-protein responsive cell line; a kit of parts adapted for use in such method and a compound when identified by such method.
Patent NZ-333132-A (NZ)
Title: Pyrolysis of waste and cracking of resultant gas
Inventor: VAN DER GIESEN ABRAHAM BAREND
IPC: B09B3/00
Filed: 1998-12-02
Abstract: Waste or biomass material is subject to pyrolysis (3) at a temperature of 350 degrees C to 650 degrees C, the released gas is cracked (5) at a temperature of 1200 to 1400 degrees C under the influence of oxygen and steam, and the pyrolysis residue is gasified (6) under a pressure of 0.5 to 1.5 bar at a temperature of 1200 to 1700 degrees C and volatized or fused under reducing conditions. The fused slag or metal concentrate is discharged or recovered and the product gases from the cracking and/or gasification stages of the process may be combined and gas cleaned or gas cleaned separately.
Patent NZ-333346-A (NZ)
Title: High-throughput screening assay systems in microscale fluidic devices
Inventor: PARCE JOHN WALLACE
IPC: G01N27/27
Filed: 1997-06-24
Abstract: An apparatus for screening test compounds for an effect on a biochemical system comprising: a)	a body having at least two intersecting channels fabricated therein, at least one of said at least two intersecting channels having at least one cross-sectional dimension in the range from about 0.1 to about 500mm b)	a source of different test compounds fluidly connected to a first of at least two intersecting channels c)	at least one component of said biochemical system fluidly connected to a second of the two intersecting channels d)	a fluid direction system for flowing said at least one component within the second of said two intersecting channels and for introducing the different test compounds from the first to the second of the two intersecting channels and e)	a detecting zone in said second channel for detecting an effect of the test compound on the biochemical system. Also claimed is the method for detecting the test compounds.
Patent NZ-333649-A (NZ)
Title: Hermetically sealed package, and method and machine for manufacturing it
Inventor: CERANI LUCA
IPC: B65D77/20
Filed: 1997-07-04
Abstract: A hermetically sealed package comprises a substantially rigid base (22), preferably a tray, a product (23) to be packaged, which in a preferred embodiment is higher than the tray side walls, supported on the tray (22), and a stretch film (15) welded to the substantially rigid base (22) along a sealing line so as to form a hermetically sealed enclosure for the product. In a method and a machine for manufacturing a hermetically sealed package (101) a stretch film (15) is stretched by means of a stretching frame (17) against a base (22) along a pressure line and is heat welded by means of a sealing frame (18) to the base (22) along a sealing line so as to form a hermetically sealed enclosure for a product (23).
Patent NZ-336674-A (NZ)
Title: Use of gabapentin in the treatment of anxiety and panic
Inventor: WOODRUFF GEOFFREY NEIL
IPC: A61K31/195
Filed: 1999-07-08
Abstract: Use of a compound of the formula above wherein, R1 is hydrogen or alkyl and n is 4, 5 or 6, for the production of a medicament for treating anxiety and panic and a purified gabapentin binding protein having the sequence EPFPSAVTIK as the first ten amino acid residues of the alpha2delta subunit.
Patent NZ-337431-A (NZ)
Title: Improved foundry alloy
Inventor: BARRESI JOSEPH GIOVANNI
IPC: B22D27/04
Filed: 1998-02-24
Abstract: n aluminium-based alloy having 6.5 - 7.5 wt.% silicon and 0.35 - 0.50 wt.% magnesium as the major alloying elements and a method of manufacturing an article from the alloy are disclosed. The alloy is characterised by a microstructure in which 'beta' phase (Al5SiFe) that forms during heat treatment as a transformation product of 'pi' phase (Al8Si6Mg3Fe) is the sole or predominant iron-containing phase in the alloy.  Also included in this invention is the method for manufacturing said alloy article.
Patent NZ-503644-A (NZ)
Title: 5-aminolevulinic acid coloured by irradiation of the crystals
Inventor: GOLUB ALLYN
IPC: C07C227/42
Filed: 1998-09-02
Abstract: Described are coloured 5-aminolevulinic acid (ALA) crystals for photodynamic therapy.  Preferably the coloured 5-aminolevulinic acid crystals have the colour imparted by irradiation of the crystals, such as gamma radiation.  The coloured ALA crystals are preferably pharmaceutically pure and sterile and can be contained in a sealed sterile container.  Also described is a sterile aqueous ALA solution that includes the coloured ALA crystals contained in water.  Also described is a method for preparing coloured ALA crystals, which includes exposing non-irradiated ALA crystals to a radiation source at a dose sufficient impart a colour which is different than any colour present in the non-irradiated crystals.  Preferably the irradiation is sufficient to sterilize the ALA crystals.  The sterile coloured ALA crystals can be used in a kit for internal or external treatment and/or detection of a condition in a mammal, which includes the sterile, coloured ALA crystals and sterile diluent, and in the case of internal treatment and/or detection optionally a catheter for administration of the ALA.
Patent NZ-505968-A (NZ)
Title: Sulfonylamino derivatives which inhibit matrix- degrading metallproteinases
Inventor: KUKKOLA PAIVI JAANA
IPC: A61K31/5375
Filed: 1999-02-02
Abstract: Sulfonylamino derivative compounds of formula (I) and their salts are disclosed wherein: Wis - OHor - NHOH; X is an optionally substituted heterocycle, NR1SO2R2, heterocyclylalkythio or CONR2R3; Y is carbon, nitrogen, oxygen or sulfur, provided that when Y is carbon, n is 2; m is 1 to 6; n is 1 or 2; Z, R1, R2, R3 and R4 are as defined in the specification. Sulfonylamino  derivative  compounds  of  formula  (I)   are inhibitors  of matrix-degrading metalloproteinases  and  are used for the treatment of related conditions.
Patent NZ-507299-A (NZ)
Title: Process of telecommunications signalling in order to establish communications paths
Inventor: HOWELL ROYAL D
IPC: H04J3/12
Filed: 1997-11-12
Abstract: A telecommunications signalling processor (400) comprising a signalling means for receiving an initial address message, an application means for processing the initial address message to select an identifier for an asynchronous communication, and a control means for transmitting a control message indicating the selected identifier is described.
Patent NZ-507392-A (NZ)
Title: Treatment of cigarette sidestream smoke to remove visible smoke particles, aerosols and to convert gases with off odours
Inventor: BOWEN LARRY
IPC: A24D1/00
Filed: 1999-04-16
Abstract: Described  is a cigarette sidestream  smoke  treatment material  made  from  a  sheet  of  non-combustible   active components  provides a porous structure capable of  treating sidestream  smoke.   The  treatment  material,  as  used  in combination  with  a cigarette, provides  a  low  sidestream smoke  emitting cigarette unit.  The material has a porosity that   encourages  a  conventional  free-burn  rate   of   a conventional  cigarette.   The  material  may   comprise   a sorbent  capable  of sorbing components  of  the  sidestream smoke,  and  an  oxygen  storage  component  which  releases oxygen  at  free-burn  rate  temperatures  to  ensure   that conventional  free-burn rate is maintained  and  to  enhance the   oxidation   treatment  of  the  adsorbed   non-aqueous components.   Preferably, an oxidation catalyst is  included in  the  material  and  most desirably  the  oxygen  storage component  may  also  function as  the  oxidation  catalyst. Particularly  preferred  materials  that  perform  the  dual function are oxides of cerium. In  Figure  1  the application of the treatment material  is shown  as  a  cigarette unit (10).  The  cigarette  unit  is adapted  by  the treatment material to emit very low  levels of  sidestream  smoke and preferably no  visible  sidestream smoke.   The  unit comprises a conventional  cigarette  (12) with  a  tobacco rod (14), which is wrapped in  conventional cigarette  paper  (16). The unit includes  a  filter  tipped portion  (18) that co-operates with the tobacco rod (12)  in providing  the  usual filtration of mainstream  smoke.   The treatment  material may be used in the shape of a tube  (20) which  surrounds  or  encompasses the cigarette  (12).   The tube  (20)  is in substantial contact with the  exterior  of the  cigarette paper (16), as shown at juncture  (22).   The tobacco  rod portion (14) preferably terminates at  the  end (24)  of  the  tube  where the tube thickness  is  generally shown  at  (26).  The tube preferably has a radial thickness in  the  range  of  0.04  mm to 1  mm.   The  overall  outer diameter  of  the  tube (20) will vary  depending  upon  the diameter of the cigarette, but can be designed in a  way  so as  not  to  increase appreciably the overall  size  of  the cigarette  unit.   The  preferred  circumferences  for   the cigarette  unit  range from 25 mm to 35 mm.   This  is  very close  to  commercially  available  conventional  cigarettes which  have circumferences in the range of 20 mm to  30  mm. The  filter  portion (18) is also preferably of  a  diameter which  is  approximately the same as the outer  diameter  of the  tube (20) so as to provide a finished looking cigarette unit.
Patent NZ-508960-A (NZ)
Title: Method of forming liposomes
Inventor: GREGORIADIS GREGORY
IPC: A61K9/127
Filed: 1999-06-16
Abstract: A method of producing a liposome preparation of/encapsulating a drug or other reagent, which method comprises the steps of (i) forming empty liposomes; (ii) mixing the liposomes from step (i) with a sugar solution and a reagent; and (iii) drying the mixture from step (ii). The compositions will generally comprise less than 10 % w/v sucrose. The method can be used to form small liposomes with high entrapment efficiency (those too large for the desired purpose can be reduced by known methods such as sonication, homogenisation and others), with a reduced number of preparation steps. It is particularly useful in the production of pharmaceuticals.
Patent NZ-509054-A (NZ)
Title: Attenuated negative strand viruses with altered Interferon antagonist activity for use as vaccines and pharmaceuticals
Inventor: PALESE PETER
IPC: A61K39/17
Filed: 1999-06-11
Abstract: An attenuated influenza virus containing two mutations and an altered interferon antagonist phenotype, wherein the first mutation is in the NS1 gene and is responsible for attenuation and permits the attenuated virus to grow to higher titers in interferon-deficient host systems as compared to interferon-competent host system, and the second mutation is not in the NS1 gene and is not responsible for the altered interferon antagonist phenotype. The virus can be used in medicaments to treat or prevent infectious diseases.
Patent NZ-509151-A (NZ)
Title: Truck or trailer mounted water treatment system
Inventor: WALKOM KEVIN MARK
IPC: B63J4/00
Filed: 2000-12-21
Abstract: A mobile water treatment system including a transport means supporting a polluted water collection means, a water treatment means, and treated water storage means. The system includes at least one vacuum pump for sucking polluted water through a vacuum hose and into an intermediate storage tank. A method of treating water using the system includes (i) collecting polluted water using the polluted water collection means (ii) treating the polluted water using the water treatment means (iii) storing treated water in the treated water storage means and (iv) transporting the system via the transport means to a dump site and dumping the treated water.
Patent NZ-512604-A (NZ)
Title: Method for removing condensables from a natural gas stream
Inventor: TJEENK WILLINK CORNELIS ANTONI
IPC: B05B1/00
Filed: 1999-12-29
Abstract: A method for removing condensables from a natural gas stream upstream of a wellhead choke connected to a subterranean formation, the method comprising the steps of: (A)  inducing the natural gas stream to flow at supersonic velocity through a conduit and thereby causing it to cool to a temperature that is below a temperature at which condensables will begin to condense forming separate droplets and/or particles; and (B)  transporting the gas and/or the condensables to a wellhead and/or re-injecting it into the subterranean formation from which it has been produced, or into a different formation, with the proviso that not all of the collected gas and condensables are re-injected into the same reservoir zone of the same formation. A well completion system for producing gas from a subterranean formation wherein said method is applied is also included.
Patent NZ-516593-A (NZ)
Title: Oral administration form for administering a fixed Tramadol and Diclofenac combination for treating pain
Inventor: BARTHOLOMAUS JOHANNES
IPC: A61K9/50
Filed: 2000-06-13
Abstract: An oral administration unit containing the active substances Tramadol and Diclofenac and/or a pharamaceutically acceptable salt thereof is disclosed, wherein the two active substances are present in subunits separately formulated in each case, in the same application unit without impairing the release profiles of the two active substances or reducing their bioavailability. Tramadol is an analgesic used to treat severe and moderately severe pain, whose mode of action is not based on a pure opioid mechanism. Tramadol also does not exhibit the characteristic side effects of an opioid.  In some cases nausea is observed as an undesirable accompanying symptom.  Other known, non-opioid analgesics suitable for treating less severe pain include steroid-free analgesics such as Diclofenac-Na, acetylsalicylic acid or Ibuprofen.
Patent NZ-523782-A (NZ)
Title: Peptides as NS3-serine protease inhibitors of hepatitis C virus
Inventor: CHEN KEVIN X
IPC: A61K38/08
Filed: 2001-07-19
Abstract: Peptides of formula (I) as NS3-serine protease inhibitors of hepatitis C virus that have HCV protease inhibitory activity and methods for preparing these peptide compounds are disclosed, wherein the variables are as defined in the specification. Pharmaceutical compositions comprising these compounds that are useful for treating disorders associated with the HCV protease are also disclosed.
Patent NZ-535389-A (NZ)
Title: Safety improvements for airport runways and taxiways by extending the width of airstrip with flexible surfacing material
Inventor: PREVOST JEAN
IPC: B64F1/36
Filed: 2003-04-03
Abstract: Safety improvements of airport runways and taxiways are achieved by providing a flexible, water-impermeable surfacing material (14) on a compacted soil base directly adjacent to an edge of airstrip shoulders (12). A synthetic grass surface (30) is provided on the area beyond the surfacing material (14) so that foreign objects such as loose particles of the airstrip shoulder materials will be driven by jet blasts and run-off across the relatively smooth texture of the surfacing material (14) and will be trapped by the synthetic grass (30), thereby minimizing foreign object damage to aircraft engines, particularly to those overhanging engines which extend well beyond the existing runway and taxiway shoulders.
Patent NZ-541689-A (NZ)
Title: Process and device for preparing phycoerythrin with high OD ratio
Inventor: CHIANG YOUNGMENG
IPC: C12M1/00
Filed: 2004-01-20
Abstract: Disclosed is a method for producing phycoerythrin with high optical density (OD), utilizing a tetraspore filament of a specific algae whose life cycle has sexual reproduction, asexual reproduction, and vegetative propagation to produce phycoerythrin with high OD, wherein the specific algae is selected from the group consisting of Galaxaura oblongata, Halymenia ceylanica, Helminthocladia australis, Porphyra dentate and the combination thereof. Also disclosed is a device for utilizing a tetraspore filament of said algae to produce phycoerythrin with high OD, comprising: a first medium to cultivate a gametophyte with mature tetrasporangia in a medium to obtain tetraspores thereof; a second medium adjacent to the first medium to cultivate the tetraspores in conditions such that the temperature, degree of illumination and light/dark ratio are respectively 15-30 deg C, 500-6000 lux and above 10:14 in order to germinate filaments; a collector positioned in the second medium to collect the cultivated filaments; a grinder adjacent to the collector to grind the cultivated filaments from the collector into powder; a mixer adjacent to the grinder to mix the ground cultivated filaments and cultivated filaments to obtain a clear-red pigment protein solution; a settler adjacent to the mixer to obtain phycoerythrin from clear-red pigment protein solution by using a salting out process.
Patent NZ-542164-A (NZ)
Title: Method for modifying pH within meat products
Inventor: ROTH ELDON
IPC: A23L13/70
Filed: 2004-03-02
Abstract: A method for injecting or forcing an ammonia-based pH modifying material into the interior of a meat product to raise the pH at one or more points within the interior of the meat product preferably to a pH above approximately 6.0. The ammonia-based pH modifying material may comprise aqueous ammonia (ammonium hydroxide solution) or a gas including some ammonia gas fraction. The temperature of the meat product may be controlled to a temperature near or just below the initial freezing temperature of the meat product during the time that the pH modifying material is injected. pH decreasing materials may be injected into the interior of the meat product either before or after injection the ammonia-based pH modifying material.
Patent NZ-547101-A (NZ)
Title: Mitochondrially targeted antioxidants
Inventor: SMITH ROBIN
Filed: 2003-08-22
Abstract: Disclosed is an antioxidant compound, comprising: a lipophilic cationic moiety selected from the group consisting of triphenylphosphonium, tribenzylammonium and phosphonium, linked by a linking moiety which comprises (C)n wherein n is an integer from 2 to 20 to an antioxidant moiety; and an anionic complement for said cationic moiety, wherein the cationic moiety is capable of mitochondrially targeting the antioxidant moiety, and wherein the anionic complement is a pharmaceutically acceptable anion comprising an alkyl sulfonate that is selected from the group consisting of methanesulfonate, ethanesulfonate and propanesulfonate.
Patent NZ-550900-A (NZ)
Title: Enhancing plant productivity by improving the plant growth medium environment with alkyl ethers of methyl oxirane-oxirane copolymer surfactants
Inventor: KOSTKA STANLEY J
IPC: A01N25/30
Filed: 2005-04-01
Abstract: Disclosed is a method for enhancing plant growth in plant growth medium which comprises the steps of: (i) preparing a surfactant composition comprising C1 - C4 alkyl ether of methyl oxirane - oxirane copolymer; and (ii) intimately contacting the plant growth medium with a bioefficaciously effective amount of said surfactant composition. Improved plant growth is realized especially with turf grasses by using an enhanced plant growth medium prepared by adding a bioefficacious amount of C1-C4 alkyl ether of methyl oxirane - oxirane copolymer that, serendipitously reduces the water repellency of the medium.
Patent NZ-551420-A (NZ)
Title: Method of screening candidate compounds for susceptibility to biliary excretion in hepatocyte cell cultures
Inventor: BROUWER KIM L
IPC: C12Q1/00
Filed: 2005-05-10
Abstract: A method of screening a candidate compound for susceptibility to biliary excretion by a hepatocyte transport protein, the method comprising: (a) providing a cell culture comprising a plurality of hepatocytes and at least one bile canaliculus, at least one of the hepatocytes comprising a transport protein; (b) exposing a candidate compound to the culture; and (c) determining an amount of the candidate compound in the at least one bile canaliculus to thereby screen the candidate compound for susceptibility to biliary excretion by the hepatocyte transport protein, comprising inhibiting expression of the hepatocyte transport protein and detecting an amount of the candidate compound present in the at least one bile canaliculus, wherein the presence of a reduced amount of the candidate compound in the at least one bile canaliculus as compared to an amount of the candidate compound in the at least one bile canaliculus when expression of the hepatocyte transport protein is not inhibited indicates the susceptibility of the candidate compound to biliary excretion by the hepatocyte transport protein.
Patent NZ-552085-A (NZ)
Title: Methods and apparatus for seperating perforated paper stock in a printer
Inventor: WEEKS DAVID E
IPC: B41J11/70
Filed: 2005-06-24
Abstract: A method for bursting perforated paper stock , comprising: feeding perforated paper stock in a feed direction along a paper path 40' in a printer 10; the perforated paper stock having sections separated by perforations; accumulating one of the sections of the perforated paper stock in a loop area 20; reversing the feed direction to draw a perforation of the accumulated section against a burst element 22 causing bursting of the perforation thereby separating the section from the perforated paper stock ; and advancing the separated section out of the loop area 20 and dispensing the section from the printer 10.